Analysis of lymphocyte populations revealed that the tumor–immune interactome in YUM-mGFP had a larger proportion of CD4+ T cells and Tregs interacting with the tumor compared to YMR-mGFP (Fig. 3D), with Tregs having the highest percentage of BFP+ expressing cells (Fig. 3E). The gene discussed is CD4; the disease is neoplasm.